Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RenovoRx

Stock_Research_Today

Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.

View narrative

US$4.20

71.9% undervalued

371.30%

Revenue growth p.a.

17 days ago

Apple

Investingwilly

Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.

View narrative

US$177.34

19.1% overvalued

14.68%

Revenue growth p.a.

2 days ago

Avino Silver & Gold Mines

Agricola

Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.

View narrative

CA$26.79

86.0% undervalued

78.01%

Revenue growth p.a.

17 days ago

RENK Group

Chris1

Community Contributor

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

In a renewed political landscape where a Trump administration adopts a more interventionist stance toward Ukraine, the United States sharply increases its military aid—providing advanced tank transmissions, power packs, and suspension systems. This pivot alleviates initial concerns among European allies, but it simultaneously reinforces the imperative for Europe to shore up its own defense capabilities.

View narrative

€69.87

14.3% undervalued

15.00%

Revenue growth p.a.

18 days ago

Load previous narratives

Allurion Technologies

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Low-dose GLP-1 Combo And FDA Approval Will Expand Obesity Care

Key Takeaways The combination therapy approach and clinical advancements are set to drive increased revenue and expand market share in obesity and related treatments. Restructuring efforts and strategic plans, including a move to B2B2C models, aim to boost efficiency, margins, and earnings moving forward.

View narrative

US$10.63

70.2% undervalued

15.87%

Revenue growth p.a.

16 days ago

Ohmyhome

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

HomerAI And Market Expansion Will Shape Real Estate Deals

Key Takeaways Strategic use of technology and AI-driven solutions is set to boost revenue through enhanced customer engagement and transaction efficiency. Expansion into high-value markets and cross-selling opportunities aim to improve revenue per transaction and long-term growth.

View narrative

US$22.00

93.2% undervalued

48.60%

Revenue growth p.a.

16 days ago

Super League Enterprise

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Diversified Portfolio And Mobile Games Will Drive Advertising Transformation

Key Takeaways Diversified revenue streams and strategic product advancements could enhance profit margins and accelerate the company's path to positive earnings. Expanding mobile gaming presence and transforming leadership could strengthen revenue opportunities and elevate the company's position in digital advertising.

View narrative

US$1.38

87.1% undervalued

16.84%

Revenue growth p.a.

16 days ago

Actelis Networks

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Federal Certification And SaaS Offerings Will Unlock Smart City Prospects

Key Takeaways Increased federal and military orders, bolstered by key certifications, position Actelis Networks for continued growth impacting future revenue positively. Expansion of software services and strategic infrastructure projects increase revenue predictability and present substantial growth opportunities.

View narrative

US$5.00

85.6% undervalued

38.74%

Revenue growth p.a.

16 days ago

Jaguar Health

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

FDA And EMA Fast-Track Approvals Will Advance Orphan Treatments

Key Takeaways New collaborations and regulatory approvals could quicken market entry, increase revenue, and improve earnings through enhanced access to global markets for orphan disease treatments. Expanding product indications and strategic launches aim to address unmet needs, potentially boosting revenue and elevating demand within targeted oncology markets.

View narrative

US$150.00

96.1% undervalued

35.75%

Revenue growth p.a.

16 days ago

Ryvyl

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Visa Direct Integration And European Partnerships Will Unlock New Markets

Key Takeaways Strong international growth and European partnerships will drive revenue impact, with strategic expansions leveraging Visa's network boosting transaction volumes. AI, blockchain, and strategic partnerships may enhance operational efficiencies, reduce costs, and promote earnings growth through improved margins and reduced compliance risks.

View narrative

US$2.75

74.9% undervalued

28.75%

Revenue growth p.a.

16 days ago

STRATA Skin Sciences

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Improved XTRAC Utilization And Expanded International Partnerships Will Secure Success

Key Takeaways Strategic removal of underperforming units and partnerships with clinics enhance device utilization and revenue potential. Growing international sales and TheraClearX adoption, coupled with insurance reimbursements, bolster future revenue prospects.

View narrative

US$10.00

73.5% undervalued

7.43%

Revenue growth p.a.

16 days ago

Freemelt Holding

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Electron Beam Powder Bed Fusion Will Unlock Diverse Industrial Opportunities

Key Takeaways Strategic focus on defense, energy, and medtech sectors positions Freemelt to capitalize on expected growth driven by geopolitical instability and technological advancements. Unique technology and strategic collaborations with industry leaders and academia may bolster revenue growth through reduced costs and increased market demand.

View narrative

SEK 2.85

52.1% undervalued

49.30%

Revenue growth p.a.

16 days ago

EverGen Infrastructure

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

RNG Production And Renewables Projects Will Exceed Capacity In 2025

Key Takeaways Increasing RNG production and major project advancements could significantly boost revenue and earnings as capacity and investments scale up. Declining operating expenses and insurance premiums may enhance net margins and bolster net earnings due to cost optimizations.

View narrative

CA$2.50

84.0% undervalued

12.76%

Revenue growth p.a.

16 days ago

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Low-dose GLP-1 Combo And FDA Approval Will Expand Obesity Care

HomerAI And Market Expansion Will Shape Real Estate Deals

Diversified Portfolio And Mobile Games Will Drive Advertising Transformation

Federal Certification And SaaS Offerings Will Unlock Smart City Prospects

FDA And EMA Fast-Track Approvals Will Advance Orphan Treatments

Visa Direct Integration And European Partnerships Will Unlock New Markets

Improved XTRAC Utilization And Expanded International Partnerships Will Secure Success

Electron Beam Powder Bed Fusion Will Unlock Diverse Industrial Opportunities

RNG Production And Renewables Projects Will Exceed Capacity In 2025

Value any company in seconds

Popular companies

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Community Investing Ideas

Low-dose GLP-1 Combo And FDA Approval Will Expand Obesity Care

HomerAI And Market Expansion Will Shape Real Estate Deals

Diversified Portfolio And Mobile Games Will Drive Advertising Transformation

Federal Certification And SaaS Offerings Will Unlock Smart City Prospects

FDA And EMA Fast-Track Approvals Will Advance Orphan Treatments

Visa Direct Integration And European Partnerships Will Unlock New Markets

Improved XTRAC Utilization And Expanded International Partnerships Will Secure Success

Electron Beam Powder Bed Fusion Will Unlock Diverse Industrial Opportunities

RNG Production And Renewables Projects Will Exceed Capacity In 2025

Value any company in seconds

Popular companies